subject: CHEBI:90196

subject_name: rac-selisistat

object_name: endometriosis


subject: CHEBI:90196

object_name: Unexplained infertility

tested_intervention: unsure


subject: CHEBI:90196

object_name: Endometrial Diseases


subject: CHEBI:90196

object_name: female; infertility, nonimplantation


subject: CHEBI:90196

object_name: uterine disease


subject: PUBCHEM.COMPOUND:44405122


subject: PUBCHEM.COMPOUND:44405122


subject: PUBCHEM.COMPOUND:44405122


subject: PUBCHEM.COMPOUND:44405122


subject: PUBCHEM.COMPOUND:44405122


subject: UMLS:C2935082


subject: UMLS:C2935082


subject: UMLS:C2935082


subject: UMLS:C2935082


subject: UMLS:C2935082


subject: CHEBI:90369

subject_name: Selisistat


subject: CHEBI:90369


subject: CHEBI:90369


subject: CHEBI:90369


subject: CHEBI:90369


subject: UMLS:C4080034

subject_name: selisistat


subject: UMLS:C4080034


subject: UMLS:C4080034


subject: UMLS:C4080034


subject: UMLS:C4080034


subject: CHEBI:28001

subject_name: Vancomycin

object_name: hematologic disorder

tested_intervention: yes


subject: CHEBI:28001

object_name: oncologic disorders


subject: CHEBI:94782

subject_name: Cediranib

object_name: cervical cancer


subject: CHEBI:94782

object_name: cervical carcinoma


subject: CHEBI:94782

object_name: peritoneum cancer


subject: CHEBI:94782

object_name: endometrial cancer


subject: CHEBI:94782

object_name: uterine corpus cancer


subject: CHEBI:94782

object_name: endometrial carcinoma


subject: CHEBI:94782

object_name: fallopian tube carcinoma


subject: CHEBI:94782

object_name: fallopian tube cancer


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: UMLS:C5391453

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:5466794

object_name: Ovarian cancer stage IV


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: FIGO Stage IIIC Ovarian Cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IIIC Ovarian Cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:5466794

object_name: FIGO Stage IIIA Ovarian Cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: stage IIIB ovarian epithelial cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:5466794

object_name: stage IV primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: recurrent primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: stage IIIA primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: stage IIIC primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: stage IIIB primary peritoneal cavity cancer


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: type 2 diabetes mellitus


subject: UNII:2S9ZZM9Q9V

object_name: Diabetes


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: esophageal cancer


subject: UMLS:C4289970

object_name: ovarian cancer


subject: UMLS:C4289970

object_name: ovarian neoplasm


subject: UMLS:C4289970

object_name: ovarian carcinoma


subject: UMLS:C4289970

object_name: bladder tumor


subject: UMLS:C4289970

object_name: urinary bladder carcinoma


subject: UMLS:C4289970

object_name: urinary bladder cancer


subject: UMLS:C4289970

object_name: childhood bladder carcinoma


subject: UMLS:C4289970

object_name: liver cancer


subject: UMLS:C4289970

object_name: liver neoplasm


subject: UMLS:C4289970

object_name: Adult Liver Carcinoma


subject: CHEBI:95073

subject_name: Ricolinostat

object_name: plasma cell myeloma


subject: UMLS:C3272774


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:49865963

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:9598

subject_name: Tiludronic acid

object_name: otosclerosis


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Medication interaction potentiation


subject: CHEBI:59527


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: PUBCHEM.COMPOUND:53701258

subject_name: 6-Mercaptopurine 6-mercaptopurine

object_name: leukemia


subject: PUBCHEM.COMPOUND:53701258

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:53701258

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:53701258

object_name: lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:53701258

object_name: Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:53701258

object_name: Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:53701258

object_name: lymphoid leukemia


subject: PUBCHEM.COMPOUND:53701258

object_name: adult acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:53701258

object_name: acute leukemia


subject: PUBCHEM.COMPOUND:53701258

object_name: T-cell leukemia


subject: CHEBI:135918

subject_name: Tucidinostat


subject: CHEBI:135918


subject: CHEBI:135918


subject: CHEBI:135918


subject: CHEBI:135918


subject: CHEBI:135918


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: Severe Acute Malnutrition


subject: UMLS:C0919075

object_name: kwashiorkor


subject: UMLS:C0919075

object_name: marasmus


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: CHEBI:10110


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63613

subject_name: Nevirapine


subject: CHEBI:63613


subject: CHEBI:63613


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Muscle Invasive Bladder Urothelial Carcinoma


subject: UMLS:C3896806


subject: CHEBI:31355

subject_name: Carboplatin


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C5228604

subject_name: enfortumab


subject: CHEBI:232556

subject_name: Erdafitinib


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:5864

subject_name: Ifosfamide


subject: UNII:73H2I6QS54

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C4726721

subject_name: sacituzumab


subject: PUBCHEM.COMPOUND:2767

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:45863

object_name: Stage II Lung Cancer AJCC v8


subject: UMLS:C5787211

object_name: endogenous depression


subject: UMLS:C5787211

object_name: major depressive disorder


subject: UNII:X7F1935FL1


subject: UNII:X7F1935FL1


subject: DRUGBANK:DB19223


subject: DRUGBANK:DB19223


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Stage II Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage II Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Carcinoma of the prostate stage II


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage II Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Carcinoma of the prostate stage III


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:131769963

object_name: prostate adenocarcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:33313

subject_name: polonium atom


subject: CHEBI:33313


subject: CHEBI:15366

subject_name: Acetic acid

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: Hemorrhage


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UMLS:C4547387

object_name: Parkinson disease


subject: CHEBI:84739

object_name: urinary tract infection


subject: CHEBI:84739

object_name: Recurrent urinary tract infections


subject: CHEBI:2637

subject_name: Amikacin


subject: CHEBI:2637


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic Malignant Genitourinary System Neoplasm


subject: CHEBI:72317

object_name: malignant testicular Leydig cell tumor


subject: CHEBI:72317

object_name: Malignant Testicular Sertoli Cell Tumor


subject: CHEBI:72317

object_name: Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma


subject: CHEBI:72317

object_name: Metastatic papillary renal cell carcinoma (disorder)


subject: CHEBI:72317

object_name: Metastatic Papillary Renal Cell Carcinoma


subject: CHEBI:72317

object_name: Metastatic Chromophobe Renal Cell Carcinoma


subject: CHEBI:72317

object_name: Metastatic chromophobe renal cell carcinoma (disorder)


subject: CHEBI:72317

object_name: Metastatic Sarcomatoid Renal Cell Carcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Squamous Cell Carcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Plasmacytoid Urothelial Carcinoma


subject: CHEBI:72317

object_name: Metastatic Prostate Small Cell Neuroendocrine Carcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Giant Cell Urothelial Carcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Large Cell Neuroendocrine Carcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Small Cell Neuroendocrine Carcinoma


subject: CHEBI:72317

object_name: Invasive Bladder Giant Cell Urothelial Carcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Micropapillary Urothelial Carcinoma


subject: CHEBI:72317

object_name: urethra clear cell adenocarcinoma


subject: CHEBI:72317

object_name: bladder clear cell adenocarcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Sarcomatoid Urothelial Carcinoma


subject: CHEBI:72317

object_name: large cell neuroendocrine carcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Lipid-Rich Urothelial Carcinoma


subject: CHEBI:72317

object_name: nested variant infiltrating bladder urothelial carcinoma


subject: CHEBI:72317

object_name: infiltrating bladder lymphoepithelioma-like carcinoma


subject: CHEBI:72317

object_name: Metastatic Kidney Medullary Carcinoma


subject: CHEBI:72317

object_name: infiltrating bladder urothelial carcinoma


subject: CHEBI:72317

object_name: Neuroendocrine carcinoma of the bladder


subject: CHEBI:72317

object_name: Metastatic Urethral Carcinoma


subject: CHEBI:72317

object_name: Metastatic Penile Cancer


subject: CHEBI:72317

object_name: Bladder cancer stage IV


subject: CHEBI:72317

object_name: bladder mixed adenocarcinoma


subject: CHEBI:72317

object_name: bladder adenocarcinoma


subject: CHEBI:72317

object_name: bladder urachal adenocarcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic Malignant Genitourinary System Neoplasm


subject: CHEBI:231679

object_name: malignant testicular Leydig cell tumor


subject: CHEBI:231679

object_name: Malignant Testicular Sertoli Cell Tumor


subject: CHEBI:231679

object_name: Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma


subject: CHEBI:231679

object_name: Metastatic papillary renal cell carcinoma (disorder)


subject: CHEBI:231679

object_name: Metastatic Papillary Renal Cell Carcinoma


subject: CHEBI:231679

object_name: Metastatic Chromophobe Renal Cell Carcinoma


subject: CHEBI:231679

object_name: Metastatic chromophobe renal cell carcinoma (disorder)


subject: CHEBI:231679

object_name: Metastatic Bladder Squamous Cell Carcinoma


subject: CHEBI:231679

object_name: Metastatic Bladder Plasmacytoid Urothelial Carcinoma


subject: CHEBI:231679

object_name: Metastatic Prostate Small Cell Neuroendocrine Carcinoma


subject: CHEBI:231679

object_name: Metastatic Bladder Giant Cell Urothelial Carcinoma


subject: CHEBI:231679

object_name: Metastatic Bladder Large Cell Neuroendocrine Carcinoma


subject: CHEBI:231679

object_name: Metastatic Bladder Small Cell Neuroendocrine Carcinoma


subject: CHEBI:231679

object_name: Invasive Bladder Giant Cell Urothelial Carcinoma


subject: CHEBI:231679

object_name: Metastatic Bladder Micropapillary Urothelial Carcinoma


subject: CHEBI:231679

object_name: urethra clear cell adenocarcinoma


subject: CHEBI:231679

object_name: bladder clear cell adenocarcinoma


subject: CHEBI:231679

object_name: Metastatic Bladder Sarcomatoid Urothelial Carcinoma


subject: CHEBI:231679

object_name: large cell neuroendocrine carcinoma


subject: CHEBI:231679

object_name: Metastatic Bladder Lipid-Rich Urothelial Carcinoma


subject: CHEBI:231679

object_name: nested variant infiltrating bladder urothelial carcinoma


subject: CHEBI:231679

object_name: infiltrating bladder lymphoepithelioma-like carcinoma


subject: CHEBI:231679

object_name: Metastatic Kidney Medullary Carcinoma


subject: CHEBI:231679

object_name: infiltrating bladder urothelial carcinoma


subject: CHEBI:231679

object_name: Neuroendocrine carcinoma of the bladder


subject: CHEBI:231679

object_name: Metastatic Penile Cancer


subject: CHEBI:231679

object_name: bladder mixed adenocarcinoma


subject: CHEBI:231679

object_name: bladder urachal adenocarcinoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic Malignant Genitourinary System Neoplasm


subject: CHEBI:231614

object_name: malignant testicular Leydig cell tumor


subject: CHEBI:231614

object_name: Malignant Testicular Sertoli Cell Tumor


subject: CHEBI:231614

object_name: Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma


subject: CHEBI:231614

object_name: Metastatic papillary renal cell carcinoma (disorder)


subject: CHEBI:231614

object_name: Metastatic Papillary Renal Cell Carcinoma


subject: CHEBI:231614

object_name: Metastatic Chromophobe Renal Cell Carcinoma


subject: CHEBI:231614

object_name: Metastatic chromophobe renal cell carcinoma (disorder)


subject: CHEBI:231614

object_name: Metastatic Bladder Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Metastatic Bladder Plasmacytoid Urothelial Carcinoma


subject: CHEBI:231614

object_name: Metastatic Prostate Small Cell Neuroendocrine Carcinoma


subject: CHEBI:231614

object_name: Metastatic Bladder Giant Cell Urothelial Carcinoma


subject: CHEBI:231614

object_name: Metastatic Bladder Large Cell Neuroendocrine Carcinoma


subject: CHEBI:231614

object_name: Metastatic Bladder Small Cell Neuroendocrine Carcinoma


subject: CHEBI:231614

object_name: Invasive Bladder Giant Cell Urothelial Carcinoma


subject: CHEBI:231614

object_name: Metastatic Bladder Micropapillary Urothelial Carcinoma


subject: CHEBI:231614

object_name: urethra clear cell adenocarcinoma


subject: CHEBI:231614

object_name: bladder clear cell adenocarcinoma


subject: CHEBI:231614

object_name: Metastatic Bladder Sarcomatoid Urothelial Carcinoma


subject: CHEBI:231614

object_name: large cell neuroendocrine carcinoma


subject: CHEBI:231614

object_name: Metastatic Bladder Lipid-Rich Urothelial Carcinoma


subject: CHEBI:231614

object_name: nested variant infiltrating bladder urothelial carcinoma


subject: CHEBI:231614

object_name: infiltrating bladder lymphoepithelioma-like carcinoma


subject: CHEBI:231614

object_name: Metastatic Kidney Medullary Carcinoma


subject: CHEBI:231614

object_name: infiltrating bladder urothelial carcinoma


subject: CHEBI:231614

object_name: Neuroendocrine carcinoma of the bladder


subject: CHEBI:231614

object_name: Metastatic Penile Cancer


subject: CHEBI:231614

object_name: bladder mixed adenocarcinoma


subject: CHEBI:231614

object_name: bladder urachal adenocarcinoma


subject: UMLS:C2346820

object_name: Metastatic Malignant Genitourinary System Neoplasm


subject: UMLS:C2346820

object_name: malignant testicular Leydig cell tumor


subject: UMLS:C2346820

object_name: Malignant Testicular Sertoli Cell Tumor


subject: UMLS:C2346820

object_name: Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Metastatic papillary renal cell carcinoma (disorder)


subject: UMLS:C2346820

object_name: Metastatic Papillary Renal Cell Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Chromophobe Renal Cell Carcinoma


subject: UMLS:C2346820

object_name: Metastatic chromophobe renal cell carcinoma (disorder)


subject: UMLS:C2346820

object_name: Metastatic Bladder Squamous Cell Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Bladder Plasmacytoid Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Prostate Small Cell Neuroendocrine Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Bladder Giant Cell Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Bladder Large Cell Neuroendocrine Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Bladder Small Cell Neuroendocrine Carcinoma


subject: UMLS:C2346820

object_name: Invasive Bladder Giant Cell Urothelial Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Bladder Micropapillary Urothelial Carcinoma


subject: UMLS:C2346820

object_name: urethra clear cell adenocarcinoma


subject: UMLS:C2346820

object_name: bladder clear cell adenocarcinoma


subject: UMLS:C2346820

object_name: Metastatic Bladder Sarcomatoid Urothelial Carcinoma


subject: UMLS:C2346820

object_name: large cell neuroendocrine carcinoma


subject: UMLS:C2346820

object_name: Metastatic Bladder Lipid-Rich Urothelial Carcinoma


subject: UMLS:C2346820

object_name: nested variant infiltrating bladder urothelial carcinoma


subject: UMLS:C2346820

object_name: infiltrating bladder lymphoepithelioma-like carcinoma


subject: UMLS:C2346820

object_name: Metastatic Kidney Medullary Carcinoma


subject: UMLS:C2346820

object_name: infiltrating bladder urothelial carcinoma


subject: UMLS:C2346820

object_name: Neuroendocrine carcinoma of the bladder


subject: UMLS:C2346820

object_name: Metastatic Penile Cancer


subject: UMLS:C2346820

object_name: bladder mixed adenocarcinoma


subject: UMLS:C2346820

object_name: bladder urachal adenocarcinoma


subject: UMLS:C3495458

subject_name: antibodies (medication)

object_name: osteopetrosis


subject: UMLS:C0813154

subject_name: Antibodies, in vitro diagnostic


subject: UMLS:C0003241

subject_name: Antibodies


subject: CHEBI:34650

subject_name: COLISTIMETHATE

object_name: ventilator-associated pneumonia


subject: CHEBI:135782

subject_name: ulobetasol propionate

object_name: acne keloid


subject: CHEBI:47898

subject_name: Epirubicin

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:27732

subject_name: Caffeine

object_name: spinal cord injury


subject: MESH:C039661

subject_name: venostasin

object_name: Edema


subject: CHEBI:44915

subject_name: Propofol

object_name: abortion


subject: CHEBI:44915

object_name: Induced Abortion Finding


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:7852

subject_name: Oxycodone

object_name: substance abuse


subject: CHEBI:135983

subject_name: Teriparatide

object_name: hip fracture


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: coronary artery disorder


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Second Primary Cancers


subject: UNII:P0GVQ9A4S5

object_name: Primary malignant neoplasm


subject: UNII:P0GVQ9A4S5

object_name: Recurrent Malignant Neoplasm


subject: UNII:P0GVQ9A4S5

object_name: Recurrent Carcinoma


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:6532

subject_name: Loperamide

object_name: Traveler's diarrhea


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: UNII:PVI5M0M1GW

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PUBCHEM.COMPOUND:16143379

subject_name: Human epidermal growth factor

object_name: Oral Mucositis


subject: PUBCHEM.COMPOUND:16143379

object_name: oral mucositis


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:185135

object_name: stomatitis


subject: CHEBI:185135


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: CHEBI:8347


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:3614


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: Agitation, CTCAE 3.0


subject: CHEBI:10119

object_name: Agitation, CTCAE 5.0


subject: CHEBI:119915

subject_name: Fentanyl

object_name: bone marrow disorder


subject: UMLS:C5667088

subject_name: Folate-receptor Alpha-targeting Ultrasmall Silica Nanoparticle-drug Conjugate ELU001

object_name: Recurrent ovarian cancer


subject: UMLS:C5667088

object_name: Recurrent Endometrial Cancer


subject: UMLS:C5667088

object_name: endometrioid tumor


subject: UMLS:C5667088

object_name: endometrial clear cell adenocarcinoma


subject: UMLS:C5667088

object_name: ovarian serous adenocarcinoma


subject: UMLS:C5667088

object_name: ovarian carcinoma


subject: UMLS:C5667088

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5667088

object_name: ovarian epithelial tumor


subject: UMLS:C5667088

object_name: endometrioid adenocarcinoma


subject: UMLS:C5667088

object_name: endometrium adenocarcinoma


subject: UMLS:C5667088

object_name: Endometrial carcinosarcoma


subject: UMLS:C5667088

object_name: ovarian adenocarcinoma


subject: UMLS:C5667088

object_name: fallopian tube carcinoma


subject: UMLS:C5667088

object_name: fallopian tube cancer


subject: UMLS:C5667088

object_name: stage, ovarian epithelial cancer


subject: UMLS:C5667088

object_name: endometrium neoplasm


subject: UMLS:C5667088

object_name: endometrial cancer


subject: UMLS:C5667088

object_name: uterine corpus cancer


subject: UMLS:C5667088

object_name: endometrial carcinoma


subject: UMLS:C5667088

object_name: Endometrial Diseases


subject: UMLS:C5667088

object_name: peritoneum cancer


subject: UMLS:C5667088

object_name: ovarian cancer


subject: UMLS:C5667088

object_name: ovarian neoplasm


subject: UMLS:C5667088

object_name: ovarian disease


subject: UMLS:C5667088

object_name: Krukenberg carcinoma


subject: PUBCHEM.COMPOUND:138376495

subject_name: Cefiderocol

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:138376495

object_name: bacterial pneumonia


subject: MESH:C433370

subject_name: Traumeel S

object_name: mucositis


subject: MESH:C433370

object_name: Neck Carcinoma


subject: MESH:C433370

object_name: head and neck neoplasm


subject: MESH:C433370

object_name: head and neck cancer


subject: UMLS:C5706488

subject_name: EED Inhibitor APG-5918

object_name: B-cell neoplasm


subject: UMLS:C5706488

object_name: non-Hodgkin lymphoma


subject: UMLS:C5706488

object_name: Ovarian clear cell carcinoma


subject: UMLS:C5706488

object_name: ovarian clear cell cancer


subject: UMLS:C5706488

object_name: nasopharyngeal carcinoma


subject: UMLS:C5706488

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5706488

object_name: epithelioid sarcoma


subject: UMLS:C5706488

object_name: adult epithelioid sarcoma


subject: UMLS:C5706488

object_name: childhood epithelioid sarcoma


subject: UMLS:C5706488

object_name: Stomach cancer


subject: UMLS:C5706488

object_name: gastric cancer


subject: UMLS:C5706488

object_name: Mesothelioma


subject: UMLS:C5706488

object_name: mesothelial neoplasm


subject: UMLS:C5706488

object_name: malignant mesothelioma


subject: UMLS:C5706488

object_name: malignant soft tissue neoplasm


subject: UMLS:C5706488

object_name: sarcoma


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: Decreased serum testosterone concentration


subject: CHEBI:6801

subject_name: Metformin

object_name: uveitis


subject: CHEBI:6801

object_name: Uveitis, CTCAE


subject: UNII:XI776WYU0N

subject_name: Sodium chromate Cr-51

object_name: G6PD deficiency


subject: UNII:XI776WYU0N

object_name: class V glucose-6-phosphate dehydrogenase deficiency


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Neuroblastoma recurrent


subject: CHEBI:64153

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: CHEBI:64153

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:64153

object_name: Disseminated neuroblastoma


subject: CHEBI:64153

object_name: Stage 4S neuroblastoma


subject: CHEBI:64153

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:64153

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:64153

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:64153

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Carcinoma breast stage IV


subject: UMLS:C2830131


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Locally Advanced Vulvar Carcinoma


subject: CHEBI:45863

object_name: vulvar squamous cell carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: DRUGBANK:DB15074

subject_name: Aglatimagene besadenovec

object_name: Grade III Childhood Astrocytoma


subject: DRUGBANK:DB15074

object_name: Adult Anaplastic Astrocytoma


subject: DRUGBANK:DB15074

object_name: anaplastic astrocytoma


subject: DRUGBANK:DB15074

object_name: Brain Stem Glioblastoma


subject: DRUGBANK:DB15074

object_name: glioma susceptibility 1


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Recovery of Function


subject: UNII:FBS8JQ0T3V

subject_name: Pterostilbene


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Capsulitis of shoulder


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9168

subject_name: Sirolimus

object_name: familial adenomatous polyposis 1


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Effects of radiation


subject: CHEBI:57694

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:57694

object_name: Prostate cancer stage I


subject: CHEBI:57694

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:57694

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:57694

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:57694

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:57694

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:57694

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:57694

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:57694

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:57694

object_name: Carcinoma of the prostate stage III


subject: CHEBI:57694

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:57694

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:57694

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:57694

object_name: Prostate cancer recurrent


subject: CHEBI:57694

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:57694

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:57694

object_name: prostate adenocarcinoma


subject: CHEBI:16243

subject_name: Quercetin

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:16243

object_name: Prostate cancer stage I


subject: CHEBI:16243

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:16243

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:16243

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:16243

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:16243

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:16243

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:16243

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:16243

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:16243

object_name: Carcinoma of the prostate stage III


subject: CHEBI:16243

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:16243

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:16243

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:16243

object_name: Prostate cancer recurrent


subject: CHEBI:16243

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:16243

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:16243

object_name: prostate adenocarcinoma


subject: UMLS:C4721941

object_name: Carcinoma breast stage IV


subject: UMLS:C2347327

subject_name: Nanoparticle Albumin-Bound Docetaxel


subject: UMLS:C2607039

object_name: schizophrenia


subject: CHEBI:167574

subject_name: Semaglutide

object_name: prostate cancer


subject: CHEBI:60791

subject_name: Xylocard

object_name: liver cancer


subject: UMLS:C0086466

subject_name: Injectables


subject: CHEBI:7514

subject_name: Neostigmine

object_name: palsy


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: Harmful pattern of substance use


subject: UNII:9603LN7R2Q

object_name: substance abuse


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:16919


subject: UMLS:C3641122

object_name: metastatic neoplasm


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX

object_name: Metastatic Lesion


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: chronic progressive multiple sclerosis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:230493

subject_name: pinometostat

object_name: myeloproliferative neoplasm


subject: CHEBI:230493

object_name: Myelodysplasia


subject: CHEBI:230493

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:230493

object_name: childhood myelodysplastic syndrome


subject: CHEBI:230493

object_name: Myelodysplastic Syndrome, CTCAE


subject: MESH:C583893


subject: MESH:C583893


subject: MESH:C583893


subject: MESH:C583893


subject: MESH:C583893


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: large cell carcinoma


subject: MESH:C520255

object_name: carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: malignant neoplasm of esophagus stage IIb


subject: UNII:7DT29059VX

object_name: papillary serous cystadenocarcinoma


subject: UNII:7DT29059VX

object_name: peritoneal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

subject_name: MAPLIRPACEPT

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: malignant epithelial tumor of ovary


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: fallopian tube carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: fallopian tube cancer


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: primary peritoneal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4802185


subject: CHEMBL.COMPOUND:CHEMBL4802185


subject: UMLS:C4725956

subject_name: SIRPa-IgG4 Fc


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C2703114

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: UMLS:C5554919

subject_name: Dalmitamig

object_name: non-small cell lung carcinoma


subject: CHEBI:5132

subject_name: Flutamide

object_name: premenstrual tension


subject: CHEBI:5132

object_name: polydactyly-myopia syndrome


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Cerebral venous thrombosis


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Chronic arthritis


subject: CHEBI:63610

object_name: myocardial ischemia


subject: CHEBI:63610

object_name: Family history of ischemic heart disease


subject: CHEBI:63610

object_name: atrial fibrillation


subject: CHEBI:63610

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:63610

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Cytokine Release Syndrome, CTCAE


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Constipation


subject: CHEBI:7514

object_name: Constipation, CTCAE


subject: CHEBI:18258

subject_name: Liothyronine

object_name: goiter


subject: CHEBI:18258

object_name: thyroid gland carcinoma


subject: CHEBI:18258

object_name: thyroid cancer


subject: CHEBI:73823

subject_name: Arg-Val

object_name: plague


subject: PUBCHEM.COMPOUND:335257

subject_name: RV


subject: UMLS:C5139895

subject_name: gosuranemab

object_name: tauopathy


subject: UMLS:C5139943


subject: CHEBI:57761

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:57761

object_name: metabolic syndrome X


subject: CHEBI:16410

subject_name: Pyridoxamine


subject: CHEBI:16410


subject: CHEBI:52763

object_name: head and neck squamous cell carcinoma


subject: CHEBI:52763

object_name: urothelial carcinoma


subject: CHEBI:52763

object_name: transitional cell carcinoma


subject: CHEBI:52763

object_name: cervical cancer


subject: CHEBI:52763

object_name: cervical carcinoma


subject: CHEBI:52763

object_name: prostate carcinoma


subject: CHEBI:52763

object_name: prostate cancer


subject: CHEBI:52763

object_name: carcinoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Endometrial neoplasm malignant metastatic


subject: UMLS:C3896806


subject: CHEBI:66910

subject_name: Axitinib


subject: GTOPDB:8313

subject_name: talazoparib


subject: CHEBI:63918

subject_name: Artesunate

object_name: Friedreich ataxia


subject: CHEBI:63918

object_name: Friedreich ataxia 1


subject: MESH:C000718012

subject_name: sucrosomial iron

object_name: inflammatory bowel disease


subject: UMLS:C5544915


subject: UNII:X6SH5T8H76

object_name: liver carcinoma


subject: UNII:B4D3WPS7JY

object_name: pancreatic neoplasm


subject: UMLS:C4745028

subject_name: RIPK1 Inhibitor GSK3145095


subject: HMDB:HMDB0014735

subject_name: Gadoteridol

object_name: brain disorder


subject: CHEBI:31643


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: complications of organ transplant stem cells


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Klatskin Tumor


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Ankle Sprains


subject: CHEBI:132922

object_name: Patent ductus arteriosus after premature birth


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: UNII:J57O328W4W

subject_name: Flindokalner

object_name: Post-Traumatic Headache


subject: CHEBI:34548


subject: UMLS:C1531444

subject_name: Maxipost


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Huntington disease


subject: CHEBI:145751

subject_name: Asn-Arg


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Recurrent urinary tract infections


subject: CHEBI:161680

subject_name: Aztreonam

object_name: bacterial infectious disease


subject: MESH:D022261

subject_name: Respiratory Syncytial Virus Vaccines

object_name: Upper Respiratory Infections


subject: MESH:D022261

object_name: respiratory tract infectious disorder


subject: CHEBI:80489

subject_name: desmethylxanthohumol

object_name: viral disease


subject: CHEBI:66331

subject_name: Xanthohumol


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Menstrual pattern


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:24848

subject_name: inositol


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C3714501

object_name: secondary progressive multiple sclerosis


subject: UMLS:C3714501

object_name: primary progressive multiple sclerosis


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: Follicular lymphoma refractory


subject: PUBCHEM.COMPOUND:91820602

object_name: Follicular lymphoma recurrent


subject: PUBCHEM.COMPOUND:91820602

object_name: Refractory Indolent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: Recurrent Indolent Adult Non-Hodgkin Lymphoma


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: UNII:R048696O9L

subject_name: Iopofosine I-131

object_name: cancer


subject: UNII:R048696O9L

object_name: neoplasm


subject: UMLS:C5575080


subject: UMLS:C5575080


subject: CHEBI:84500

subject_name: varenicline

object_name: Dependence


subject: GTOPDB:8268

subject_name: veltuzumab

object_name: autoimmune thrombocytopenic purpura


subject: UNII:BPD4DGQ314


subject: UMLS:C1529789


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Autoimmunity


subject: CHEBI:28787

object_name: scleroderma


subject: CHEBI:28787

object_name: systemic sclerosis


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class

object_name: West syndrome


subject: UMLS:C3714638

object_name: Infantile Spasm


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: KEGG.COMPOUND:C00046

subject_name: RNA

object_name: Frontal balding


subject: PR:000023786

subject_name: ribonuclease I


subject: CHEBI:31215

subject_name: anecortave

object_name: Coats disease


subject: UMLS:C5418088

subject_name: Anti-RANKL Monoclonal Antibody GB-223

object_name: bone cancer


subject: UMLS:C5418088

object_name: bone neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:176975

object_name: malignant soft tissue neoplasm


subject: CHEBI:176975

object_name: sarcoma


subject: CHEBI:176975

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:176975

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:176975

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:176975

object_name: soft tissue sarcoma


subject: UMLS:C5417966


subject: UMLS:C5417966


subject: UMLS:C5417966


subject: UMLS:C5417966


subject: UMLS:C5417966


subject: UMLS:C5417966


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: post operative nausea and vomiting


subject: UMLS:C0030956

subject_name: Peptides

object_name: Malaria, Vivax


subject: CHEBI:33474

subject_name: hydrocarbylidyne group


subject: UMLS:C2745348

object_name: multiple sclerosis


subject: UMLS:C2745348

object_name: Parkinson disease


subject: UMLS:C2745348

object_name: Alzheimer disease type 1


subject: UMLS:C2745348

object_name: Alzheimer disease


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: endometrial polyp


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: Solid Neoplasm


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Carcinoma liver resectable


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C1541395


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: glioma


subject: UMLS:C4083270

object_name: malignant glioma


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: pancreatic adenocarcinoma


subject: UNII:P0GVQ9A4S5

object_name: small intestine adenocarcinoma


subject: UNII:P0GVQ9A4S5

object_name: adrenal carcinoma


subject: UNII:P0GVQ9A4S5

object_name: adrenal cortex carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:P0GVQ9A4S5

object_name: Adult Soft Tissue Sarcoma


subject: UNII:P0GVQ9A4S5

object_name: sarcoma


subject: UNII:P0GVQ9A4S5

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:P0GVQ9A4S5

object_name: soft tissue sarcoma


subject: UNII:P0GVQ9A4S5

object_name: carcinoma of the ampulla of vater


subject: UNII:P0GVQ9A4S5

object_name: Duodenal Cancer


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: endometriosis


subject: UNII:9U7D5QH5AE


subject: CHEBI:16899

subject_name: Mannitol


subject: CHEBI:177833

subject_name: Cilengitide


subject: UMLS:C0764377


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: adverse effect to anesthesia


subject: CHEBI:4466

object_name: Tinnitus, Spontaneous Oto-Acoustic Emission


subject: CHEBI:4466

object_name: hyperreflexia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:4856

subject_name: Esmolol


subject: CHEBI:4856


subject: CHEBI:4856


subject: CHEBI:30742

subject_name: macrogol

object_name: peripheral nerve injury


subject: PR:000012224

subject_name: glycodelin


subject: UMLS:C0723612

subject_name: Tears Again

object_name: xerophthalmia


subject: UMLS:C0723612

object_name: dry eye syndrome


subject: UMLS:C0723612

object_name: Dry Eye Syndrome, CTCAE


subject: CHEBI:23965

subject_name: estradiol

object_name: sexual disorder


subject: CHEBI:23965

object_name: Bowel incontinence


subject: CHEBI:23965

object_name: obstetric; injury pelvic floor


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: filarial elephantiasis


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Effects of chemotherapy


subject: MESH:C079198

object_name: Surgical procedure finding


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:16822

subject_name: choline sulfate

object_name: Liver Disease Associated with Cystic Fibrosis


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate

object_name: non-small cell lung carcinoma


subject: CHEBI:27375

subject_name: Vinblastine


subject: UMLS:C3657751

object_name: ataxia telangiectasia


subject: UMLS:C4733694

subject_name: Falbikitug


subject: UMLS:C4733694

object_name: pancreatic neoplasm


subject: UMLS:C4733694

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4733694

object_name: malignant pancreatic neoplasm


subject: UMLS:C4733694

object_name: ovarian cancer


subject: UMLS:C4733694

object_name: ovarian neoplasm


subject: UMLS:C4733694

object_name: ovarian carcinoma


subject: CHEBI:36704

subject_name: Imiquimod

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Chronic myeloid leukemia, BCR/ABL-positive


subject: UNII:2158753C7E

subject_name: Relacorilant

object_name: Food-Drug Interactions


subject: CHEBI:63660

object_name: leukemia


subject: CHEBI:63660

object_name: childhood leukemia


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Congenital Disorders


subject: CHEBI:93775

subject_name: Amethopterin

object_name: urticaria


subject: CHEBI:93775

object_name: reported urticaria (physical finding)


subject: CHEBI:93775

object_name: Urticaria, CTCAE


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Asthenozoospermia


subject: CHEBI:7986

object_name: Reduced sperm motility


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Childhood Solid Neoplasm


subject: GTOPDB:13085

object_name: Adult Solid Neoplasm


subject: GTOPDB:13085

object_name: Solid Neoplasm


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: CHEBI:81783

subject_name: Tricyclazole

object_name: adult lymphoma


subject: CHEBI:81783

object_name: lymphoma


subject: CHEBI:81783

object_name: pediatric lymphoma


subject: UMLS:C4521565

subject_name: Beam -- chemical


subject: UMLS:C4521565


subject: UMLS:C4521565


subject: UMLS:C0795577

subject_name: recombinant antihemophilic factor VIII

object_name: severe hemophilia A


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: acquired polycythemia vera


subject: UNII:T4H8FMA7IM

object_name: myelofibrosis


subject: UNII:T4H8FMA7IM

object_name: thrombocytopenia


subject: CHEMBL.COMPOUND:CHEMBL5095287

subject_name: ROSNILIMAB

object_name: ulcerative colitis


subject: CHEMBL.COMPOUND:CHEMBL5095287

object_name: inflammatory bowel disease 1


subject: UMLS:C5670503

subject_name: Rosnilimab


subject: UMLS:C5670503


subject: UMLS:C4045746

object_name: Diabetic peripheral neuropathic pain


subject: CHEBI:37956

subject_name: histamine antagonist

object_name: primary progressive multiple sclerosis


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:5339

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:5339

object_name: breast cancer


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: rheumatoid arthritis


subject: CHEBI:6942

subject_name: Minoxidil

object_name: Endocrine Therapy-Induced Alopecia


subject: CHEBI:6942

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:6942

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:6933

subject_name: Midodrine

object_name: Neurogenic Orthostatic Hypotension


subject: CHEBI:8665

subject_name: Pyridostigmine


subject: CHEBI:86319

subject_name: 25-hydroxyvitamin D2

object_name: psoriasis


subject: CHEBI:17933

subject_name: Calcifediol


subject: GTOPDB:5962

subject_name: dovitinib

object_name: adrenal carcinoma


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: asthma


subject: UniProtKB:P0AED9

subject_name: DCM_ECOLI DNA-cytosine methyltransferase (sprot)

object_name: brain neoplasm


subject: PR:000001803

subject_name: C-C motif chemokine 28


subject: PR:000022407

subject_name: DNA-cytosine methyltransferase


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:175901

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:175901

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:175901

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:175901

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:175901


subject: CHEBI:47898

subject_name: Epirubicin

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:47898

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:47898

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:47898

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1971343

subject_name: Injection, ranibizumab, 0.1 mg administered

object_name: Myopic choroidal neovascularization


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: CHEBI:6121

subject_name: Ketamine

object_name: substance abuse


subject: CHEBI:8080

subject_name: Phentermine


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Alzheimer disease type 1


subject: CHEBI:49662

object_name: Alzheimer disease


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Skin Carcinoma


subject: CHEBI:47381

subject_name: Diclofenac

object_name: blood coagulation disease


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Friction blister


subject: CHEBI:74705

object_name: Bulla


subject: CHEBI:74705

object_name: Blister of skin AND/OR mucosa


subject: CHEBI:74705

object_name: Skin bulla


subject: CHEBI:74705

object_name: Blistering eruption


subject: CHEBI:74705

object_name: epidermolysis bullosa


subject: CHEBI:74705

object_name: Varicose ulcer of lower extremity


subject: CHEBI:74705

object_name: Cutaneous wound


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:68606

subject_name: Rilpivirine

object_name: Cognitive impairment


subject: UMLS:C5555578

object_name: Solid Neoplasm


subject: UMLS:C4310469

subject_name: Mencevax ACWY

object_name: hepatitis B


subject: UMLS:C4310469

object_name: diphtheria


subject: UMLS:C4310469

object_name: tetanus


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: common cold


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:17561

subject_name: Cysteine


subject: UMLS:C4733271

subject_name: SB injection

object_name: Stomach cancer


subject: UMLS:C4733271

object_name: gastric cancer


subject: CHEBI:177762

subject_name: Alovudine

object_name: brain neoplasm


subject: CHEBI:177762

object_name: cancer


subject: CHEBI:177762

object_name: neoplasm


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000007563


subject: PR:000007563


subject: CHEBI:15366

subject_name: Acetic acid


subject: CHEBI:15366


subject: CHEBI:15366


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:3636

subject_name: Chloroprocaine

object_name: pregnancy related


subject: UMLS:C0675788

subject_name: Eovist

object_name: liver carcinoma


subject: UMLS:C2713349

subject_name: Nebido

object_name: Angina pectoris


subject: UNII:3412470A0V

subject_name: melflufen

object_name: kidney failure


subject: UNII:F70C5K4786

subject_name: Melphalan flufenamide


subject: CHEBI:28939

object_name: Abnormal renal physiology


subject: CHEBI:28939

object_name: Acetylcysteine adverse reaction


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:7421


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: vulvodynia


subject: UMLS:C5706488

subject_name: EED Inhibitor APG-5918

object_name: anemia


subject: UMLS:C5706488

object_name: Anemia, CTCAE


subject: UNII:9G1A824CC2

object_name: sensorineural hearing loss disorder


subject: UMLS:C5827885

subject_name: Abrysvo

object_name: Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site


subject: UMLS:C5827885

object_name: respiratory system disorder


subject: UMLS:C5827885

object_name: lower respiratory tract disorder


subject: UMLS:C5239084

object_name: Biochemically Recurrent Prostate Carcinoma


subject: UMLS:C5239084

object_name: Localized Prostate Carcinoma


subject: UMLS:C5239084

object_name: prostate adenocarcinoma


subject: DRUGBANK:DB16564

subject_name: Mucopolysaccharide polysulphate

object_name: pancreatic neoplasm


subject: DRUGBANK:DB16564

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB16564

object_name: malignant pancreatic neoplasm


subject: CHEBI:18358

subject_name: Methoxsalen


subject: CHEBI:18358


subject: CHEBI:18358


subject: CHEBI:8107

subject_name: Phenytoin


subject: CHEBI:8107


subject: CHEBI:8107


subject: PR:000017033

object_name: diabetes mellitus


subject: UMLS:C0074512

subject_name: Signal Recognition Particle


subject: DRUGBANK:DB13906

subject_name: Aloe vera leaf


subject: CHEMBL.COMPOUND:CHEMBL2108221

subject_name: ALOE


subject: CHEMBL.COMPOUND:CHEMBL2108221

object_name: periodontitis, chronic, adult


subject: CHEMBL.COMPOUND:CHEMBL2108221

object_name: chronic periodontitis


subject: UMLS:C0304554

subject_name: aloe extract


subject: UMLS:C0304554


subject: UMLS:C0304554


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: liver carcinoma


subject: UMLS:C3896858

subject_name: bemarituzumab

object_name: transitional cell carcinoma


subject: UMLS:C2987342

object_name: Childhood Breast Carcinoma


subject: UMLS:C2987342

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2109092

subject_name: EPOETIN BETA

object_name: hepatitis C


subject: CHEMBL.COMPOUND:CHEMBL2109092

object_name: chronic hepatitis C virus infection


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: Raynaud disease


subject: UNII:30868AY0IF

object_name: carpal tunnel syndrome


subject: CHEBI:135193

subject_name: Fospropofol


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Increased reactive oxygen species production


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: UNII:F64QU97QCR

subject_name: Dantrolene

object_name: Cerebral Vasospasm


subject: UNII:F64QU97QCR

object_name: subarachnoid hemorrhage


subject: CHEBI:143528

subject_name: DL-Arabinose

object_name: Critical Illness


subject: CHEBI:143528

object_name: malnutrition


subject: UNII:89NA02M4RX

subject_name: PECTIN


subject: UNII:89NA02M4RX


subject: CHEBI:17309

subject_name: pectin


subject: CHEBI:17309


subject: CHEMBL.COMPOUND:CHEMBL2109337

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2346795

subject_name: MDX-1342 antibody


subject: UMLS:C1541530

object_name: alveolar soft part sarcoma


subject: CHEBI:42588

subject_name: Fenretinide

object_name: cystic fibrosis


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: thymic epithelial neoplasm


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Periodontal inflammation


subject: CHEBI:150712

object_name: Periodontal Attachment Loss


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:33349

subject_name: dubnium atom

object_name: Wound healed (finding)


subject: CHEBI:33349

object_name: Periodontal Pocket


subject: CHEBI:33349


subject: CHEBI:33349


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:33357


subject: CHEBI:33357


subject: CHEBI:33357


subject: CHEBI:133630

subject_name: His-Ala


subject: CHEBI:133630


subject: CHEBI:133630


subject: CHEBI:133630


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03456


subject: UniProtKB:P03456


subject: UniProtKB:P03456


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:P03446


subject: UniProtKB:P03446


subject: UniProtKB:P03446


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0


subject: UniProtKB:A3DRP0


subject: UniProtKB:A3DRP0


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143


subject: UniProtKB:A4K143


subject: UniProtKB:A4K143


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6


subject: UniProtKB:B4URD6


subject: UniProtKB:B4URD6


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UniProtKB:Q0A448


subject: UniProtKB:Q0A448


subject: UniProtKB:Q0A448


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UMLS:C4285347


subject: UMLS:C4285347


subject: UMLS:C4285347


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:Q9WCD8


subject: UniProtKB:Q9WCD8


subject: UniProtKB:Q9WCD8


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:P03453


subject: UniProtKB:P03453


subject: UniProtKB:P03453


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6


subject: UniProtKB:A4U7A6


subject: UniProtKB:A4U7A6


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P13103


subject: UniProtKB:P13103


subject: UniProtKB:P13103


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P26136


subject: UniProtKB:P26136


subject: UniProtKB:P26136


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:P07976


subject: UniProtKB:P07976


subject: UniProtKB:P07976


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7


subject: UniProtKB:A4GBX7


subject: UniProtKB:A4GBX7


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:P19698


subject: UniProtKB:P19698


subject: UniProtKB:P19698


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:P03457


subject: UniProtKB:P03457


subject: UniProtKB:P03457


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9


subject: UniProtKB:A4GCL9


subject: UniProtKB:A4GCL9


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3


subject: UniProtKB:Q9WFX3


subject: UniProtKB:Q9WFX3


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2


subject: UniProtKB:A4U6V2


subject: UniProtKB:A4U6V2


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5


subject: UniProtKB:Q07FI5


subject: UniProtKB:Q07FI5


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:P03454


subject: UniProtKB:P03454


subject: UniProtKB:P03454


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8


subject: UniProtKB:A4GCK8


subject: UniProtKB:A4GCK8


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:P03448


subject: UniProtKB:P03448


subject: UniProtKB:P03448


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7


subject: UniProtKB:A4GCJ7


subject: UniProtKB:A4GCJ7


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:P04661


subject: UniProtKB:P04661


subject: UniProtKB:P04661


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60


subject: UniProtKB:Q0HD60


subject: UniProtKB:Q0HD60


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:P26139


subject: UniProtKB:P26139


subject: UniProtKB:P26139


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5


subject: UniProtKB:A4GCH5


subject: UniProtKB:A4GCH5


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: childhood onset asthma


subject: UMLS:C3658854


subject: UNII:HX101E7L6S

subject_name: oregovomab

object_name: Carcinoma of peritoneum


subject: UNII:HX101E7L6S

object_name: peritoneal carcinoma


subject: UNII:HX101E7L6S

object_name: fallopian tube neoplasm


subject: UNII:HX101E7L6S

object_name: fallopian tube adenocarcinoma


subject: UNII:HX101E7L6S

object_name: peritoneal neoplasm


subject: UNII:HX101E7L6S

object_name: fallopian tube serous adenocarcinoma


subject: UNII:HX101E7L6S

object_name: ovarian serous adenocarcinoma


subject: UMLS:C0664206

subject_name: Ovarex


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: UMLS:C0664206


subject: CHEBI:44915

subject_name: Propofol

object_name: superficial epidermolytic ichthyosis


subject: CHEBI:44915

object_name: irritable bowel syndrome


subject: CHEBI:44915

object_name: polyp


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Diabetes


subject: UMLS:C0013227

object_name: diabetes mellitus


subject: UMLS:C0013227

object_name: Prediabetes


subject: UMLS:C0013227

object_name: inherited lipid metabolism disorder


subject: UMLS:C0013227

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0013227

object_name: obesity


subject: UMLS:C0013227

object_name: Obesity, CTCAE


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Abnormal renal physiology


subject: CHEBI:3654

subject_name: Chlorthalidone


subject: UMLS:C0537895

object_name: candidiasis


subject: UMLS:C2368489

subject_name: Topotecan, oral, 0.25 mg

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C2368489

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C2368489

object_name: anaplastic astrocytoma


subject: UMLS:C2368489

object_name: glioblastoma


subject: UMLS:C2368489

object_name: Childhood Glioblastoma


subject: UMLS:C2368489

object_name: adult glioblastoma


subject: UMLS:C2368489

object_name: Adult Gliosarcoma


subject: UMLS:C2368489

object_name: gliosarcoma


subject: UMLS:C2368489

object_name: Childhood Gliosarcoma


subject: CHEBI:90528

subject_name: Neflamapimod

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:151890382

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Restless legs


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Advanced Gastric Adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: Advanced Urothelial Carcinoma


subject: UNII:PQX0D8J21J

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672

object_name: Metastatic Colorectal Adenocarcinoma


subject: CHEBI:4672


subject: CHEBI:4672


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:91512

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: CHEBI:3540

subject_name: cephalotaxine


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:4975

subject_name: Famotidine

object_name: Dyskinesia


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614

object_name: viral pneumonia


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:164593978

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:164593978

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:164593978

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:164593978

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:164593978

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:164593978

object_name: non-small cell lung carcinoma


subject: CHEBI:64816

object_name: ALK-negative anaplastic large cell lymphoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: enteropathy-associated T-cell lymphoma


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: CHEBI:8378


subject: CHEBI:8378

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:143658


subject: CHEBI:15377

subject_name: Water

object_name: Renal artery stenosis


subject: CHEBI:15377

object_name: kidney failure


subject: CHEBI:15377

object_name: Renal Failure, CTCAE


subject: UMLS:C3642261

subject_name: Copper Cu 62 Ethylglyoxal Bis(thiosemicarbazone)


subject: UMLS:C3642261


subject: UMLS:C3642261


subject: CHEBI:134958

subject_name: thioacetazone


subject: CHEBI:134958


subject: CHEBI:134958


subject: CHEBI:156467

subject_name: thiosemicarbazone


subject: CHEBI:156467


subject: CHEBI:156467


subject: MESH:D013882

subject_name: Thiosemicarbazones


subject: MESH:D013882


subject: MESH:D013882


subject: UMLS:C0007507

subject_name: Antigens, CD25

object_name: acute myeloid leukemia


subject: UMLS:C0007507

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C0007507

object_name: myoclonic dystonia 11


subject: UMLS:C0007507

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0007507

object_name: acute lymphoblastic leukemia


subject: UMLS:C0007507

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0007507

object_name: non-Hodgkin lymphoma


subject: UMLS:C0007507

object_name: plasma cell myeloma


subject: UMLS:C0007507

object_name: Hodgkin Disease


subject: UMLS:C0007507

object_name: juvenile myelomonocytic leukemia


subject: PR:000001380

subject_name: interleukin-2 receptor subunit alpha


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: PR:000001380


subject: UMLS:C0004149

subject_name: ATGAM


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: GTOPDB:13769

subject_name: retatrutide

object_name: Insulin Sensitivity


subject: GTOPDB:13769

object_name: diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL5095485

subject_name: RETATRUTIDE


subject: CHEMBL.COMPOUND:CHEMBL5095485


subject: UMLS:C3526551

subject_name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus (DTaP-IPV) Vaccine

object_name: haemophilus infectious disease


subject: UMLS:C0247947

subject_name: exendin (9-39)

object_name: Prediabetes


subject: CHEBI:95165

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:45716

subject_name: Vorinostat

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:15365

subject_name: Aspirin

object_name: Stage 3 chronic kidney disease


subject: CHEBI:15365

object_name: Stage 4 chronic kidney disease


subject: CHEBI:167309

subject_name: Methadone

object_name: drug dependence


subject: CHEBI:167309

object_name: AIDS


subject: CHEBI:132922

object_name: anxiety


subject: CHEBI:132922

object_name: anxiety disorder


subject: CHEBI:132922

object_name: Anxiety symptoms


subject: CHEBI:132922

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:132922

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:145421

object_name: childhood myelodysplastic syndrome


subject: CHEBI:145421

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Papulopustular Rosacea


subject: CHEBI:49086

object_name: Non-arteritic ischemic optic neuropathy


subject: CHEBI:16436

subject_name: Citicoline


subject: UMLS:C3248655

subject_name: Injection, eribulin mesylate, 0.1 mg

object_name: Carcinoma breast stage IV


subject: UMLS:C3248655

object_name: Breast cancer recurrent


subject: UMLS:C5203265

subject_name: Eribulin Mesylate Liquid Injection


subject: UMLS:C5203265


subject: UMLS:C5222443

subject_name: Fulvestrant Injection


subject: UMLS:C5222443


subject: PUBCHEM.COMPOUND:5620

subject_name: SPIRADOLINE

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:5620

object_name: bipolar depression


subject: UMLS:C5227659

object_name: interstitial lung disease 2


subject: CHEBI:149504

object_name: hyperlipidemia


subject: CHEBI:149504

object_name: hyperlipoproteinemia


subject: CHEBI:149504

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:149504

object_name: Serum lipids high (finding)


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: Exercise-induced lactic acidemia


subject: UMLS:C0000392

subject_name: beta-alanine


subject: CHEBI:177531

subject_name: Liafensine

object_name: treatment resistant depression


subject: CHEBI:177531


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class

object_name: colorectal cancer


subject: UMLS:C3714638

object_name: colorectal carcinoma


subject: UMLS:C3714638

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5201250

subject_name: PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1

object_name: High-Grade Squamous Intraepithelial Lesions


subject: UMLS:C5201250

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Ischemic stroke


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:40799

subject_name: Boldione

object_name: atrial fibrillation


subject: CHEBI:40799

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:40799

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C5964845

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:2269

object_name: Pediatric Crohn's disease


subject: PUBCHEM.COMPOUND:2269

object_name: inflammatory bowel disease 1


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: Hepatic impairment


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Disorder of retina caused by radiation


subject: GTOPDB:8932

subject_name: pepinemab

object_name: Alzheimer disease type 1


subject: GTOPDB:8932

object_name: Alzheimer disease


subject: UNII:BPZ4A29SYE

subject_name: PEPINEMAB


subject: UNII:BPZ4A29SYE


subject: UMLS:C3272653


subject: UMLS:C3272653


subject: CHEBI:41423

subject_name: Celecoxib

object_name: renal cell adenocarcinoma


subject: CHEBI:41423

object_name: kidney cancer


subject: CHEBI:41423

object_name: renal cell carcinoma


subject: CHEBI:41423

object_name: childhood kidney cell carcinoma


subject: CHEBI:41423

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:41423

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C0021735

subject_name: Viraferon


subject: PUBCHEM.COMPOUND:9832423

subject_name: Vytorin

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:9832423

object_name: atherosclerosis


subject: RXCUI:476348

subject_name: ezetimibe / simvastatin Oral Tablet


subject: RXCUI:476348


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Langerhans cell histiocytosis


subject: CHEBI:17579

subject_name: Beta carotene

object_name: congenital alveolar dysplasia


subject: CHEBI:17579

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:17579

object_name: newborn respiratory distress syndrome


subject: CHEBI:17579

object_name: Neonatal necrotizing enterocolitis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: coronary restenosis


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C5937792

subject_name: avibactam / aztreonam

object_name: Infection


subject: UMLS:C5937792

object_name: infectious disease


subject: UMLS:C5937792

object_name: Adverse Event Associated with Infection


subject: UMLS:C5937792

object_name: Antibiotic Resistance, Microbial


subject: CHEBI:3286

subject_name: Cabergoline

object_name: female reproductive system disorder


subject: UNII:CY3QT94KWP

object_name: basal cell carcinoma


subject: UNII:CY3QT94KWP

object_name: skin basal cell carcinoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Neck pain


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Vomiting, Postoperative


subject: CHEBI:41879

object_name: Depth of anesthesia


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Postoperative Nausea


subject: CHEBI:7773


subject: CHEBI:49956

subject_name: Xenon


subject: CHEBI:49956


subject: CHEBI:49956


subject: UNII:43J9Q56T3W

subject_name: Serabelisib

object_name: Neck Carcinoma


subject: UNII:43J9Q56T3W

object_name: head and neck neoplasm


subject: UNII:43J9Q56T3W

object_name: head and neck cancer


subject: UNII:43J9Q56T3W

object_name: colorectal carcinoma


subject: UNII:43J9Q56T3W

object_name: Childhood Breast Carcinoma


subject: UNII:43J9Q56T3W

object_name: breast carcinoma


subject: UNII:43J9Q56T3W

object_name: breast cancer


subject: UNII:43J9Q56T3W

object_name: lung cancer


subject: UNII:43J9Q56T3W

object_name: lung neoplasm


subject: UNII:43J9Q56T3W

object_name: lung carcinoma


subject: CHEBI:90942

subject_name: Ixazomib

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:90942

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:90942

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:90942

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:90942

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:90942

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:90942

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:90942

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:90942

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:90942

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:90942

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:90942

object_name: adult acute monocytic leukemia


subject: CHEBI:90942

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:90942

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:90942

object_name: Adult Erythroleukemia


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: central nervous system cancer


subject: UNII:3Q6PPC19PO


subject: UMLS:C4331803

subject_name: MDM2-p53 Inhibitor APG-115

object_name: chronic myelomonocytic leukemia


subject: UMLS:C4331803

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4331803

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C4331803

object_name: Myelodysplasia


subject: UMLS:C4331803

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C4331803

object_name: myoclonic dystonia 11


subject: GTOPDB:13455

subject_name: felzartamab


subject: UNII:3O9FA4XC02


subject: UMLS:C3273720


subject: PUBCHEM.COMPOUND:166177189

subject_name: Nerandomilast

object_name: interstitial lung disease


subject: UNII:I5DGT51IB8

subject_name: NERANDOMILAST


subject: CHEBI:64073

object_name: Drug-induced obesity


subject: CHEBI:64073

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:64073

object_name: metabolic syndrome X


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UMLS:C5417784

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5557664


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3274703

object_name: colorectal cancer


subject: UMLS:C3274703

object_name: colorectal carcinoma


subject: UMLS:C3274703

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Plasmodium falciparum malaria


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:4953

subject_name: Exemestane

object_name: Node-negative breast cancer


subject: CHEBI:41774

subject_name: Tamoxifen


subject: DRUGBANK:DB19006

subject_name: Vepdegestrant

object_name: breast neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4802181

object_name: Childhood Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4802181

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4802181

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4802181

object_name: Refractory Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4802181

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C5556654

subject_name: Anti-CD47 Monoclonal Antibody STI-6643


subject: UMLS:C5556654


subject: UMLS:C5556654


subject: UMLS:C5556654


subject: UMLS:C5556654


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: mood disorder


subject: CHEBI:85995

subject_name: lenvatinib mesylate

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:85995

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:85995

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:85995

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:85995

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:85995

object_name: Unresectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:85995

object_name: Advanced Pancreatic Ductal Adenocarcinoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:1351PE5UGS

subject_name: Elotuzumab

object_name: Post-polycythemia vera myelofibrosis


subject: UNII:1351PE5UGS


subject: UNII:1351PE5UGS

object_name: myelofibrosis


subject: CHEBI:72296

subject_name: Apixaban

object_name: punctate palmoplantar keratoderma type III


subject: CHEBI:124965

subject_name: Opaganib

object_name: Kaposi Sarcoma


subject: CHEBI:124965

object_name: diffuse large B-cell lymphoma


subject: UMLS:C2933332


subject: UMLS:C2933332


subject: UMLS:C2933331

subject_name: Yeliva


subject: UMLS:C2933331


subject: CHEBI:8485

subject_name: Proparacaine

object_name: Traumatic injection site


subject: CHEBI:8485

object_name: Injection site infection


subject: CHEBI:8485

object_name: diabetic macular edema


subject: CHEBI:8485

object_name: Post-Operative Pain


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: diabetic neuropathy


subject: CHEBI:75722

subject_name: Tramadol

object_name: Neonatal infection


subject: UNII:8XZ281AO3G

object_name: Alzheimer disease type 1


subject: UNII:8XZ281AO3G

object_name: Presenile dementia


subject: UNII:8XZ281AO3G

object_name: dementia


subject: UNII:8XZ281AO3G

object_name: cognitive disorder


subject: UMLS:C0301869

subject_name: Immunostimulating conjugate (antigen)

object_name: Haemophilus influenzae Type b Infection


subject: UMLS:C0301869

object_name: meningococcal meningitis


subject: MESH:D017778

subject_name: Vaccines, Combined


subject: MESH:D017778


subject: UMLS:C2945718

subject_name: Lupin protein

object_name: Hypercholesterolemia


subject: DRUGBANK:DB11355

subject_name: Propolis wax

object_name: Recurrent urinary tract infections


subject: CHEBI:83162

subject_name: propolis extract


subject: DRUGBANK:DB14275

subject_name: Indian frankincense


subject: UMLS:C5971076

subject_name: boswellia (chemical)


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: CHEBI:140421

subject_name: Betrixaban

object_name: Hepatic impairment


subject: UMLS:C5235658

subject_name: Targeted Therapy Agent

object_name: metastatic colorectal cancer


subject: CHEBI:28171

object_name: endogenous depression


subject: CHEBI:28171

object_name: major depressive disorder


subject: UMLS:C5417868

subject_name: Perenostobart

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1816356

subject_name: Tetrastarch

object_name: Abdominal Compartment Syndrome


subject: UMLS:C3495434

subject_name: hydroxyethyl starch 130-0.4


subject: PUBCHEM.COMPOUND:166158894

object_name: Diabetic peripheral neuropathic pain


subject: UNII:7CS0WNO31M

subject_name: QUININE HYDROCHLORIDE


subject: CHEBI:52251

subject_name: QUININE SULFATE


subject: CHEBI:94416


subject: CHEBI:15854

subject_name: Quinine


subject: UMLS:C5206793

subject_name: MDM2 Antagonist ASTX295

object_name: Childhood Solid Neoplasm


subject: UMLS:C5206793

object_name: Adult Solid Neoplasm


subject: UMLS:C5206793

object_name: Solid Neoplasm


subject: CHEBI:74824

subject_name: Thr-Ala

object_name: Placenta Previa


subject: PUBCHEM.COMPOUND:4532223

subject_name: Tantalum


subject: PR:000006886

subject_name: ectodysplasin-A


subject: PR:000016550


subject: CHEBI:6129

subject_name: Ketorolac

object_name: aortic dissection


subject: CHEBI:6129

object_name: Aortic dissection


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: endometrial endometrioid adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: endometrial serous adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: endometrial mixed adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: endometrial undifferentiated carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: undifferentiated carcinoma of the corpus uteri


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Uterine Corpus Cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: Metastatic endometrioid carcinoma


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Secondary malignant neoplasm of skin


subject: CHEBI:75045

object_name: skin neoplasm


subject: UMLS:C3838813

subject_name: BRAF inhibitor (product)

object_name: skin melanoma


subject: UMLS:C3838813

object_name: BRAF gene mutation


subject: UMLS:C3838813


subject: UMLS:C3838813


subject: MESH:C000629782

subject_name: talimogene laherparepvec


subject: MESH:C000629782


subject: MESH:C000629782


subject: MESH:C000629782


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: PUBCHEM.COMPOUND:135742497

subject_name: MEK inhibitor


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: PUBCHEM.COMPOUND:135742497


subject: UMLS:C2347168

subject_name: Mitogen-Activated Protein Kinase Kinase Inhibitor


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: UMLS:C2347168


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Sepsis


subject: CHEBI:474053

object_name: Sepsis, CTCAE


subject: CHEBI:474053

object_name: Premature infant


subject: CHEBI:474053

object_name: Premature birth


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: vitamin D deficiency


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: scurvy


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: infectious disease


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:4026

object_name: Colorectal cancer recurrent


subject: CHEBI:4026

object_name: Stage IVB Pancreatic Cancer


subject: CHEBI:4026

object_name: Pancreatic carcinoma stage IVA


subject: CHEBI:4026

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:4026

object_name: colorectal adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Renal cell carcinoma recurrent


subject: UNII:3A58010674

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:3A58010674

object_name: Melanoma recurrent


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: Breast cancer recurrent


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: Stage IV Renal Cell Cancer


subject: UNII:3A58010674

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:3A58010674

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:WP6PY72ZH3

subject_name: Motolimod


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3

object_name: Non-small cell lung cancer recurrent


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3

object_name: Solid Neoplasm


subject: UNII:WP6PY72ZH3

object_name: Metastatic non-small cell lung cancer


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:WP6PY72ZH3

object_name: Carcinoma breast stage IV


subject: UNII:WP6PY72ZH3

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:WP6PY72ZH3

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:33704

subject_name: Amino acid

object_name: neuroendocrine neoplasm


subject: CHEBI:33704

object_name: Childhood Neuroblastoma


subject: CHEBI:33704

object_name: neuroblastoma


subject: CHEBI:33704

object_name: medulloblastoma


subject: CHEBI:33704

object_name: childhood medulloblastoma


subject: CHEBI:33704

object_name: adult medulloblastoma


subject: CHEBI:33704

object_name: Adult Meningioma


subject: CHEBI:33704

object_name: benign meningioma


subject: CHEBI:33704

object_name: familial meningioma


subject: CHEBI:33704

object_name: pediatric meningioma


subject: CHEBI:33704

object_name: meningioma


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: UMLS:C0662900

object_name: leukopenia


subject: UMLS:C0662900

object_name: neutropenia


subject: CHEBI:176838

subject_name: vitamin B2

object_name: migraine


subject: CHEBI:176838

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEMBL.COMPOUND:CHEMBL2108389

subject_name: FEVERFEW


subject: CHEMBL.COMPOUND:CHEMBL2108389


subject: UNII:6GE7Z0761K

subject_name: feverfew extract


subject: UNII:6GE7Z0761K


subject: UNII:0P49L952WZ

subject_name: Andrographis paniculata extract


subject: UNII:0P49L952WZ


subject: CHEBI:46245

subject_name: Ubidecarenone


subject: CHEBI:46245


subject: PUBCHEM.COMPOUND:66586232

object_name: Cross Infection


subject: PUBCHEM.COMPOUND:66586232

object_name: Upper Respiratory Infections


subject: PUBCHEM.COMPOUND:66586232

object_name: respiratory tract infectious disorder


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227

object_name: Surgical Wound Infection


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UNII:BMO5G62HGB

subject_name: FLORBETABEN

object_name: complete trisomy 21


subject: UNII:BMO5G62HGB

object_name: Down syndrome


subject: CHEBI:79033

subject_name: florbetaben F18


subject: CHEBI:79033


subject: UMLS:C2352589


subject: UMLS:C2352589


subject: UMLS:C5828908

object_name: Alcohol interaction


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: IMAGe syndrome


subject: UMLS:C3898831

object_name: Warburg Effect


subject: UMLS:C3898831

object_name: neoplasm


subject: MESH:C534042

subject_name: kalinox

object_name: Acute Pain


subject: CHEBI:149504

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:134735

subject_name: Omarigliptin

object_name: chronic kidney disease


subject: CHEBI:134735

object_name: Chronic uremia


subject: CHEBI:94366

subject_name: itraconazole

object_name: dermatophytosis


subject: CHEBI:94366

object_name: tinea corporis